These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 197272)

  • 1. Correlation of virus polypeptide structure with attenuation of poliovirus type 1.
    Milstien JB; Walker JR; Eron LJ
    J Virol; 1977 Sep; 23(3):811-5. PubMed ID: 197272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in three of the four coat proteins of oral polio vaccine strain derived from type 1 poliovirus.
    Kew OM; Pallansch MA; Omilianowski DR; Rueckert RR
    J Virol; 1980 Jan; 33(1):256-63. PubMed ID: 6245231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid composition of the poliovirus capsid polypeptides isolated as fluorescamine conjugates.
    Wouters M; Vandekerckhove J
    J Gen Virol; 1976 Dec; 33(3):529-33. PubMed ID: 187727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolution of the major poliovirus capsid polypeptides into doublets.
    Vrijsen R; Wouters M; Boeye A
    Virology; 1978 May; 86(2):546-55. PubMed ID: 27002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stepwise degradation of poliovirus capsid by alkaline treatment.
    Katagiri S; Aikawa S; Hinuma Y
    J Gen Virol; 1971 Oct; 13(1):101-9. PubMed ID: 4331807
    [No Abstract]   [Full Text] [Related]  

  • 6. Isoelectric points of polypeptides of standard poliovirus particles of different serological types and of empty capsids and dense particles of poliovirus type 1.
    Hamann A; Reichel C; Wiegers KJ; Drzeniek R
    J Gen Virol; 1978 Mar; 38(3):567-70. PubMed ID: 204736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polypeptide composition of poliovirions, naturally occurring empty capsids, and 14S precursor particles.
    Phillips BA; Fennell R
    J Virol; 1973 Aug; 12(2):291-9. PubMed ID: 4355933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleic acid sequence of the region of the genome encoding capsid protein VP1 of neurovirulent and attenuated type 3 polioviruses.
    Stanway G; Cann AJ; Hauptmann R; Mountford RC; Clarke LD; Reeve P; Minor PD; Schild GC; Almond JW
    Eur J Biochem; 1983 Oct; 135(3):529-33. PubMed ID: 6311539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cleavage of poliovirus-specific polypeptide aggregates.
    Korant BD
    J Virol; 1973 Sep; 12(3):556-63. PubMed ID: 4355854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VP 4, the D-reactive part of poliovirus.
    Breindl M
    Virology; 1971 Dec; 46(3):962-4. PubMed ID: 4332986
    [No Abstract]   [Full Text] [Related]  

  • 11. Structural proteins of poliovirus type 2 isolates.
    Yoneyama T; Hagiwara A; Hara M
    Microbiol Immunol; 1981; 25(6):575-83. PubMed ID: 6268945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction and comparison of secondary structures of poliovirus capsid proteins.
    Yang XF; He J; Wang H; Guo R
    Proc Chin Acad Med Sci Peking Union Med Coll; 1986; 1(2):109-13. PubMed ID: 2829159
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of supraoptimal temperature on poliovirus type 1 Mahoney strain reproduction.
    Mikhejeva A; Ghendon Yu
    Arch Gesamte Virusforsch; 1974; 45(1-2):65-77. PubMed ID: 4370475
    [No Abstract]   [Full Text] [Related]  

  • 14. A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain.
    Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
    J Virol; 1988 Aug; 62(8):2828-35. PubMed ID: 2839704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of two determinants that attenuate vaccine-related type 2 poliovirus.
    Ren RB; Moss EG; Racaniello VR
    J Virol; 1991 Mar; 65(3):1377-82. PubMed ID: 1847458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse neurovirulence determinants of poliovirus type 1 strain LS-a map to the coding regions of capsid protein VP1 and proteinase 2Apro.
    Lu HH; Yang CF; Murdin AD; Klein MH; Harber JJ; Kew OM; Wimmer E
    J Virol; 1994 Nov; 68(11):7507-15. PubMed ID: 7933134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic and biochemical characterization of poliovirus type 1 isolates of non-vaccine origin.
    Hara M; Hagiwara A; Yoneyama T; Saito Y; Shimojo H
    Microbiol Immunol; 1983; 27(12):1057-65. PubMed ID: 6328228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative biochemical studies of type 3 poliovirus.
    Minor PD
    J Virol; 1980 Apr; 34(1):73-84. PubMed ID: 6246264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structure of heated poliovirus particles.
    Breindl M
    J Gen Virol; 1971 Jun; 11(3):147-56. PubMed ID: 4105288
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell clones cured of persistent poliovirus infection display selective permissivity to the wild-type poliovirus strain Mahoney and partial resistance to the attenuated Sabin 1 strain and Mahoney mutants.
    Calvez V; Pelletier I; Couderc T; Pavio-Guédo N; Blondel B; Colbère-Garapin F
    Virology; 1995 Oct; 212(2):309-22. PubMed ID: 7571400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.